HAYWARD, Calif., Sept. 5, 2017 /PRNewswire/ -- Impax
Laboratories, Inc. (NASDAQ: IPXL) today announced that
Paul Bisaro, President and Chief
Executive Officer, and Bryan
Reasons, Senior Vice President and Chief Financial Officer,
will participate in a fireside chat at the Morgan Stanley
15th Annual Global Healthcare Conference in New York, NY on Tuesday, September 12 at 10:35 a.m. Eastern Time.
Individuals may listen to the live or an archived presentation
made at the conference, which will be posted in the investor
relations section of the Company's web site at
www.impaxlabs.com. This presentation will be archived on the
Company's web site for 90 days.
About Impax Laboratories, Inc.
Impax Laboratories,
Inc. (Impax) is a specialty pharmaceutical company applying its
formulation expertise and drug delivery technology to the
development of controlled-release and specialty generics in
addition to the development of central nervous system disorder
branded products. Impax markets its generic products through its
Impax Generics division and markets its branded products through
the Impax Specialty Pharma division. Additionally, where
strategically appropriate, Impax develops marketing partnerships to
fully leverage its technology platform and pursues partnership
opportunities that offer alternative dosage form technologies, such
as injectables, nasal sprays, inhalers, patches, creams, and
ointments.
For more information, please visit the Company's Web site at:
www.impaxlabs.com.
Company
Contact:
Mark Donohue
Investor Relations and Corporate Communications
(215)
558-4526
www.impaxlabs.com
View original
content:http://www.prnewswire.com/news-releases/impax-to-present-at-the-morgan-stanley-15th-annual-global-healthcare-conference-300513700.html
SOURCE Impax Laboratories, Inc.